Cookies Policy

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.

I accept this policy

Find out more here

Nitrosothiol-based NO-donors inhibit the gastrointestinal mucosal damaging actions of NSAIDs

No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
The full text of this article is not currently available.

Brill’s MyBook program is exclusively available on BrillOnline Books and Journals. Students and scholars affiliated with an institution that has purchased a Brill E-Book on the BrillOnline platform automatically have access to the MyBook option for the title(s) acquired by the Library. Brill MyBook is a print-on-demand paperback copy which is sold at a favorably uniform low price.

Access this article

+ Tax (if applicable)
Add to Favorites
You must be logged in to use this functionality

image of Inflammopharmacology

Piroxicam dose- and time-dependently induced gastric lesions in rats. The piroxicam-induced gastric lesions, both in acute (18-h) and in sub-chronic (3- and 14-day) treatments, were significantly inhibited by co-administration with the standard nitric oxide (NO) donor, S-nitrosoglutathione (GSNO). The extent of inhibition of lesion formation was dependent on the doses of both piroxicam and GSNO. GSNO affected neither the pharmacokinetics nor the pharmacological effect of piroxicam in the phenylbenzoquinone-induced writhing test. A new structural class of NSAIDs which contains a nitrosothiol moiety linked by a tether to a NSAID by an ester bond was synthesized. Ketoprofen-SNO (NMI-246) and ibuprofen-SNO (NMI-172) were designed to release NO in the gastrointestinal (GI) tract and liberate their respective parent NSAID. These SNO-NSAIDs were GI-sparing and equipotent to their respective parent NSAID in both the rat carrageenan-induced paw edema and phenylbenzoquinone-induced writhing tests. In conclusion, combination of NSAIDs with NO-donors or NSAID derivatives with a NO-donating moiety are effective GI-sparing antiinflammatory analgesics.


Full text loading...


Data & Media loading...

Article metrics loading...



Can't access your account?
  • Tools

  • Add to Favorites
  • Printable version
  • Email this page
  • Subscribe to ToC alert
  • Get permissions
  • Recommend to your library

    You must fill out fields marked with: *

    Librarian details
    Your details
    Why are you recommending this title?
    Select reason:
    Inflammopharmacology — Recommend this title to your library
  • Export citations
  • Key

  • Full access
  • Open Access
  • Partial/No accessInformation